Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials.

Cabanski CR, Yang E, Stewart MD, Allen JD, Connolly JE, Dugan U, Greenberg PD, Mackall CL, June CH, Marson A, Maus MV, Ribas A